<DOC>
	<DOCNO>NCT02684500</DOCNO>
	<brief_summary>The purpose research study determine diameter flow superior mesenteric artery patient aneurysmal subarachnoid hemorrhage undergo hypertensive therapy cerebral artery vasospasm effect enough justify withhold enteral nutrition .</brief_summary>
	<brief_title>Aneurysmal Subarachnoid Hemorrhage Superior Mesenteric Artery Flow Study</brief_title>
	<detailed_description>Study measurement diameter Doppler flow velocity superior mesenteric artery ( SMA ) use abdominal ultrasound order evaluate potential additional risk non-occlusive mesenteric ischemia ( NOMI ) non occlusive bowel necrosis ( NOBN ) patient undergo hypertensive therapy cerebral vasospasm Aneurysmal Subarachnoid Hemorrhage ( aSAH ) , justify withhold enteral nutrition .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Patient diagnose aSAH Hemodynamic instability Already receive vasopressor therapy Nonaneurysmal SAH Intracranial hemorrhage cause Not anticipate receive hypertensive therapy vasoactive medication cerebral vasospasm SAH suspect aSAH Unable visualize SMA use ultrasound Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>aSAH</keyword>
</DOC>